Management of congenital toxoplasmosis in France: current data

Congenital toxoplasmosis is caused by transplacental contamination of the fetus withToxoplasma gondiifollowing maternal primary infection. The risk of mother-to-child transmission depends on the term of pregnancy at the time of maternal infection. The risk is lower than 5% in the first trimester but...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	La Presse médicale (1983) 2010-05, Vol.39 (5), p.530-538
Hauptverfasser:	Garcia-Méric, Patricia, Franck, Jacqueline, Dumon, Henri, Piarroux, Renaud
Format:	Artikel
Sprache:	fre
Schlagworte:	Antiprotozoal Agents - therapeutic use Coccidiostats - therapeutic use Female France Humans Infant, Newborn Infectious Disease Transmission, Vertical - prevention & control Mass Screening Population Surveillance Pregnancy Prenatal Diagnosis Pyrimethamine - therapeutic use Spiramycin - therapeutic use Sulfonamides - therapeutic use Toxoplasmosis, Congenital - drug therapy Toxoplasmosis, Congenital - transmission
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!